| ラトビア | トルコ | オーストリア | |
| 骨髄移植術 | - | から $36,000 | から $140,000 |
| 非血縁者間同種骨髄移植術 | - | から $71,500 | から $180,000 |
| 選択的アフェレーシス | - | から $1,550 | - |
| 血漿交換術 | - | から $1,200 | から $2,000 |
| 血漿交換 | - | から $3,900 | - |
Bookimedは血液腫瘍科治療価格に追加料金を加算しません。料金はクリニックの公式価格表から来ています。国に到着時にクリニックで治療代を直接お支払いいただきます。
Bookimedはお客様の安全に取り組んでいます。血液腫瘍科治療で高い国際基準を維持し、世界中の国際患者サービスに必要なライセンスを有する医療機関とのみ協力しています。
Bookimedは無料専門サポートを提供します。専属医療コーディネーターが治療前、治療中、治療後にサポートし、あらゆる問題を解決します。血液腫瘍科治療の旅路でお一人になることはありません。
The Latvian Oncology Centre at Riga East University Hospital is the primary hub for cancer care. It handles 80% of oncology cases in Latvia. Complex blood disorders like leukemia are managed here or at Pauls Stradins Clinical University Hospital. Both centers are located in Riga.
Bookimed Expert Insight: Patient volume reflects quality trends in Latvia. Facilities like Baltic Vein Clinic perform 1,500+ procedures yearly. High-volume centers in Riga typically secure more insurance contracts. This often leads to smoother administrative processing for international patients.
Patient Consensus: Patients note that major centers in the capital city are the standard for advanced blood disorder care. It is important to bring all medical records and pathology results to your first appointment.
Latvian specialists treat a wide range of blood cancers and benign disorders. These include acute and chronic leukemias, Hodgkin and non-Hodgkin lymphomas, and multiple myeloma. Clinics also manage myeloproliferative neoplasms and non-malignant conditions like complex anemias, coagulation disorders, and immune-related platelet issues.
Bookimed Expert Insight: Latvian hematology centers often integrate conventional oncology with immunology. Pallas Clinic in Jūrmala specializes in combining traditional protocols with dendritic cell therapy. This integrative approach attracts patients seeking customized biological treatments alongside standard chemotherapy regimens. This trend reflects Latvia's growing role as a hub for personalized immunotherapy.
Patient Consensus: Patients note that bringing historical blood count results and iron studies speeds up the diagnostic process. While hematologists handle complex malignancies, many suggest visiting a family doctor first for routine iron-deficiency issues.
Latvia offers specialized targeted therapies and virotherapy through advanced clinical centers in Riga and Jurmala. The country serves as the historic center for oncolytic virotherapy development. Patients access targeted treatments, genetic profiling, and integrative protocols like Dendritic Cell Therapy at certified facilities.
Bookimed Expert Insight: Patient data shows a trend toward combining conventional care with immunology in Jurmala. Pallas Clinic manages about 100 oncology cases annually using this hybrid approach. While specialized, these clinics focus on smaller patient volumes to ensure highly personalized scheduling. This makes Latvia a viable choice for patients seeking specific Advanced Medical Therapeutical Products.
Patient Consensus: Patients note that standard care is reliable through the public system. However, they emphasize that advanced therapies often require private payment due to government quotas. Some advise seeking second opinions to confirm if non-standard options meet specific medical needs.
International patients can obtain remote second medical opinions from Latvian oncology specialists. Clinics utilize digital record submission for pathology and imaging review. The process follows Latvia's Medical Treatment Law regarding telemedicine. Specialized centers provide formal written reports or video consultations.
Bookimed Expert Insight: Private clinics like Pallas Clinic in Jūrmala focus on personalized immunology. These centers often coordinate niche therapies like Advanced Medical Therapeutical Products. Smaller private facilities frequently offer faster turnaround times for record reviews. This helps international patients receive specialized oncology guidance within days.
Patient Consensus: Patients emphasize translating all medical files before submission to prevent delays. Many suggest confirming whether a single doctor or a full team performs the review.